Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in ICU Patients

Among critically ill patients in the intensive care unit (ICU), complications are frequent, including stress ulcers in the upper gastrointestinal tract. To help prevent the development of ulcers, antagonism of gastric acid (with antacids historically) or inhibition of the production of acid (with histamine-2 receptor blockers more recently) were implemented as part of routine critical care. The introduction of proton pump inhibitors, with data demonstrating improved ulcer prevention and recovery compared with histamine-2 receptor blockers in non –critically ill patients, led many physicians who provide care for critically ill patients to incorporate proton pump inhibitors for routine stress ulcer prophylaxis. However, the lack of randomized clinical trials (RCTs) that directly compared histamine-2 receptor blockers with proton pump inhibi tors for stress ulcer prophylaxis in critically ill patients, combined with decreasing incidence of significant gastrointestinal bleeding in these patients and emerging evidence of an association between proton pump inhibitor use and adverse events, including Clostridioides difficile (Clostridium di fficile) infection, cognitive decline, and nosocomial pneumonia, made the optimal choice of routine stress ulcer prophylaxis less clear.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research

Related Links:

AbstractBackgroundRisks of thyroidectomy for multinodular goiter (MNG) in older and frail patients are unclear, particularly regarding hematoma and recurrent laryngeal nerve (RLN) palsy.MethodsMNG patients undergoing total thyroidectomy were reviewed in the ACS-NSQIP procedure-targeted database (2016 –2017). Outcomes were analyzed between adult (age
Source: World Journal of Surgery - Category: Surgery Source Type: research
This study is registered at ClinicalTrials.gov (NCT02027896).FindingsBetween March 14, 2014, and May 24, 2019, 27 701 patients were screened, of whom 7780 were eligible. 2970 of these were enrolled and randomly assigned to receive accelerated surgery (n=1487) or standard care (n=1483). The median time from hip fracture diagnosis to surgery was 6 h (IQR 4–9) in the accelerated-surgery group and 24 h (10–42) in the standard-care group (p
Source: The Lancet - Category: General Medicine Source Type: research
Ibrutinib is a new first-line drug for treating chronic lymphocytic leukemia (CLL), and could change frontline treatment of CLL from traditional IV chemotherapy to oral targeted therapy. Lymphocytosis often worsens with initiation of ibrutinib, but typically resolves over 6 to 18 months. Though patients generally tolerate ibrutinib well, the drug can cause adverse reactions including hypertension, atrial fibrillation, bleeding, and infections such as fungal pneumonia.
Source: Journal of the American Academy of Physician Assistants - Category: Primary Care Tags: What's New in Cardiology Source Type: research
ConclusionsCompared with rhTM alone, combination of rhTM with antithrombin for severe community-acquired pneumonia-associated disseminated intravascular coagulation may be ineffective for reducing mortality and may increase bleeding.
Source: Journal of Intensive Care - Category: Intensive Care Source Type: research
This study is registered with ClinicalTrials.gov, number NCT02180724, and is ongoing, but no longer enrolling.FindingsBetween Sept 8, 2014, and Dec 24, 2015, 122 patients were assessed for eligibility, of which 106 (87%) patients were given acalabrutinib (14 were treatment naive and 92 had relapsed or refractory disease). With a median follow-up of 27·4 months (IQR 26·0–29·7), 13 (93% [95% CI 66–100]) of 14 treatment naive patients achieved an overall response and 86 (93% [86–98]) of 92 relapsed or refractory patients per both the modified 3rd and 6th IWWM criteria. Seven (50%) of 14 ...
Source: The Lancet Haematology - Category: Hematology Source Type: research
Conclusions Overall, a majority of patients recovered well postoperatively with minimal complications and low rate of reoperation. Our research provides a foundation to develop a risk-stratified approach to determine the need for an ICU admission or early transfer to floor care.
Source: Annals of Plastic Surgery - Category: Cosmetic Surgery Tags: Microsurgery Source Type: research
We report two cases of acquired factor XIII deficiency with bleeding events during veno-venous extracorporeal membrane oxygenation (ECMO). Case 1: A 76-year-old man diagnosed with aspiration pneumonia after near-drowning was started on ECMO. Later, the patient presented with hemoptysis and anemia. Blood tests showed a decreased factor XIII activity of 29%. Although the patient recovered after receiving 1200 International Units of factor XIII concentrate, the patient had another episode of decreased factor XIII activity and bloody stool and was treated again with factor XIII concentrate. Case 2: A 48-year-old female diagnos...
Source: Journal of Artificial Organs - Category: Transplant Surgery Source Type: research
Diffuse alveolar hemorrhage (DAH) may occur with vasculitis, infection, and coagulation disorders. In patients with hematologic malignancies such as leukemia, lymphoma and multiple myeloma, the risk of death from DAH is 70%. Although their effectiveness remains uncertain, corticosteroids are the mainstay of treatment. It is not easy to determine the use of corticosteroids because of the adverse effects such as worsening of infections, gastrointestinal (GI) bleeding and poor blood glucose control. Retrospective analysis was performed at a single medical center in South Korea from August 2005 to April 2018. DAH was diagnosed...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Rare ILD/DPLD Source Type: research
Background and Objectives: Histopathology is a key element for the multidisciplinary diagnosis of diffuse parenchymal lung diseases (DPLD). We aimed to evaluate the efficacy, safety and diagnostic utility of bronchoscopic transbronchial cryobiopsy in diagnosing DPLD in Egyptian population and to identify the common DPLD pathologies in them.Methods: A prospective interventional study that enrolled 25 Egyptian patients presented to Main Alexandria University Hospital (Egypt) who had clinical and radiologic features of DPLD, but insufficient elements to achieve definite features of usual interstitial pneumonia (UIP/IPF) in ch...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: ILD/DPLD of known origin Source Type: research
This study investigate the effectiveness of radial endobronchial ultrasound – transbronchial biopsy (R-EBUS-TBB) with thin bronchoscope in peripheral lung lesions. We compared the diagnostic yields and complication rates of REBUS-TBB with CT-PTNB in a total of 199 patients with peripheral lung lesions. Of the total 199 men, 120 were men and the mean age was 67.6 ± 12.5 years. The left upper lobe was 61 (30.7%) and right upper lobe was 59 (29.6%). 68.8% of the 137 confirmed cases were diagnosed as malignant. The diagnotic accuracy of R-EBUS-TBB in 56 patients was lower than CT-PTNB in 179 patients with statisti...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Interventional pulmonology Source Type: research
More News: American Medical Association (AMA) | Bleeding | Clinical Trials | Gastroenterology | General Medicine | Intensive Care | Pneumonia | Proton Pump Inhibitors PPIs